Evasins: Therapeutic Potential of a New Family of Chemokine-Binding Proteins from Ticks
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evasins: Therapeutic Potential of a New Family of Chemokine-Binding Proteins from Ticks
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-06-07
DOI
10.3389/fimmu.2016.00208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- De novoisolation of antibodies with pH-dependent binding properties
- (2015) Pauline Bonvin et al. mAbs
- Immune modulation by virus-encoded secreted chemokine binding proteins
- (2015) Haleh Heidarieh et al. VIRUS RESEARCH
- pH-dependent antigen-binding antibodies as a novel therapeutic modality
- (2014) T. Igawa et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- A 24-48 h fed Amblyomma americanum tick saliva immuno-proteome
- (2014) Željko M Radulović et al. BMC GENOMICS
- Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display
- (2014) Pauline Bonvin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis
- (2014) Yaniv Zohar et al. JOURNAL OF CLINICAL INVESTIGATION
- Biased and G Protein-Independent Signaling of Chemokine Receptors
- (2014) Anne Steen et al. Frontiers in Immunology
- Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models
- (2013) Maud Déruaz et al. FEBS Journal
- Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice
- (2013) Vincent Braunersreuther et al. THROMBOSIS AND HAEMOSTASIS
- Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
- (2012) M. S. Fineman et al. DIABETES OBESITY & METABOLISM
- Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
- (2012) David G Parkes et al. Expert Opinion on Drug Discovery
- A Deep Insight into the Sialotranscriptome of the Gulf Coast Tick, Amblyomma maculatum
- (2011) Shahid Karim et al. PLoS One
- Therapeutic Effects of Evasin-1, a Chemokine Binding Protein, in Bleomycin-Induced Pulmonary Fibrosis
- (2010) Remo C. Russo et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- An insight into the sialotranscriptome of the brown dog tick, Rhipicephalus sanguineus
- (2010) Elen Anatriello et al. BMC GENOMICS
- Pan-CC Chemokine Neutralization Restricts Splenocyte Egress and Reduces Inflammation in a Model of Arthritis
- (2010) V. Buatois et al. JOURNAL OF IMMUNOLOGY
- Evasin-3-like anti-chemokine activity in salivary gland extracts of ixodid ticks during blood-feeding: a new target for tick control
- (2010) I. VANČOVÁ et al. PARASITE IMMUNOLOGY
- Neutrophil-Derived CCL3 Is Essential for the Rapid Recruitment of Dendritic Cells to the Site of Leishmania major Inoculation in Resistant Mice
- (2010) Mélanie Charmoy et al. PLoS Pathogens
- Treatment with a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice from Experimental Colitis
- (2009) Angélica T. Vieira et al. AMERICAN JOURNAL OF PATHOLOGY
- Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease
- (2009) Sandra Miklos et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Anti-chemokine activities of ixodid ticks depend on tick species, developmental stage, and duration of feeding
- (2009) Iveta Vančová et al. VETERINARY PARASITOLOGY
- Ticks produce highly selective chemokine binding proteins with antiinflammatory activity
- (2008) Maud Déruaz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The direct thrombin inhibitor hirudin
- (2008) Theodore Warkentin et al. THROMBOSIS AND HAEMOSTASIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started